Pollack S L, Hunt J S, Polse K A
Am J Optom Physiol Opt. 1981 May;58(5):361-6. doi: 10.1097/00006324-198105000-00003.
Using double-masking procedures, the mydriatic and cycloplegic effects of 0.25, 0.5, 0.75, and 1.0% tropicamide were studied. All doses produced clinically useful mydriasis of at least 6-mm pupils. Using testing conditions of both normal (35 ft-c) and bright (150 ft-c) illumination, no mydriatic dose-response differences for the four concentrations were found. Cycloplegic effects were dose related. A single drop of either 0.75 or 1.0% tropicamide reduced the amplitude of accommodation to about 1.5 D, which is adequate for a cycloplegic refraction.
采用双盲程序,研究了0.25%、0.5%、0.75%和1.0%托吡卡胺的散瞳和睫状肌麻痹作用。所有剂量均产生了临床上有用的散瞳效果,瞳孔至少散大到6毫米。在正常(35英尺烛光)和明亮(150英尺烛光)照明两种测试条件下,未发现这四种浓度的散瞳剂量反应差异。睫状肌麻痹作用与剂量相关。一滴0.75%或1.0%的托吡卡胺可使调节幅度降低至约1.5 D,这足以用于睫状肌麻痹验光。